Exosome proteomics reveals transcriptional regulator proteins with potential to mediate downstream pathways

Cancer Science

Volumn 105, Issue 11, 2014, Pages 1384-1392

  Ung, Timothy H ^a   Madsen, Helen J ^a   Hellwinkel, Justin E ^a   Lencioni, Alex M ^a   Graner, Michael W ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Exosomes; Gene ontology; Proteomics; Transcriptional regulators

Indexed keywords

DNA BINDING PROTEIN; PROTEOME; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR;

EXOSOME; EXTRACELLULAR SPACE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; NEOPLASM; PROTEOMICS; SIGNAL TRANSDUCTION;

DNA-BINDING PROTEINS; EXOSOMES; EXTRACELLULAR SPACE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; PROTEOME; PROTEOMICS; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84911390789     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12534     Document Type: Review

References (83)

1. Simpson RJ, Jensen SS, Lim JW. Proteomic profiling of exosomes: current perspectives. Proteomics 2008; 8: 4083-99.
2. Nickel W, Rabouille C. Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol 2009; 10: 148-55.
3. Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem 1987; 262: 9412-20.
4. Simons M, Raposo G. Exosomes-Vesicular carriers for intercellular communication. Curr Opin Cell Biol 2009; 21: 575-81.
5. Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 2013; 200: 373-83.
6. Raimondo F, Morosi L, Chinello C, Magni F, Pitto M. Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery. Proteomics 2011; 11: 709-20.
7. Tan A, De La Pena H, Seifalian AM. The application of exosomes as a nanoscale cancer vaccine. Int J Nanomedicine 2010; 5: 889-900.
8. Sun D, Zhuang X, Zhang S et al. Exosomes are endogenous nanoparticles that can deliver biological information between cells. Adv Drug Deliv Rev 2013; 65: 342-7.
9. Johnstone RM. The Jeanne Manery-Fisher Memorial Lecture 1991. Maturation of reticulocytes: formation of exosomes as a mechanism for shedding membrane proteins. Biochem Cell Biol 1992; 70: 179-90.
10. Vlassov AV, Magdaleno S, Setterquist R, Conrad R. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta 2012; 1820: 940-8.
11. Gruenberg J, Stenmark H. The biogenesis of multivesicular endosomes. Nat Rev Mol Cell Biol 2004; 5: 317-23.
12. Pant S, Hilton H, Burczynski ME. The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem Pharmacol 2012; 83: 1484-94.
13. Graner MW. Brain tumor exosomes and microvesicles: Pleiotropic effects from tiny cellular surrogates. In: Garami M, ed. Molecular Targets of CNS Tumors. InTech: Rijeka, Croatia, InTech Open Access 2012; 43-78.
14. Zomer A, Vendrig T, Hopmans ES, van Eijndhoven M, Middeldorp JM, Pegtel DM. Exosomes: fit to deliver small RNA. Commun Integr Biol 2010; 3: 447-50.
15. Batagov AO, Kuznetsov VA, Kurochkin IV. Identification of nucleotide patterns enriched in secreted RNAs as putative cis-acting elements targeting them to exosome nano-vesicles. BMC Genomics 2011; 12(Suppl 3): S18.
16. Gibbings DJ, Ciaudo C, Erhardt M, Voinnet O. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol 2009; 11: 1143-9.
17. Skog J, Wurdinger T, van Rijn S et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008; 10: 1470-6.
18. Nieuwenhuysen P, Heremans K, Clauwaert J. High-pressure scattering study of Artemia salina ribosomes and polysomes. Biochim Biophys Acta 1980; 606: 292-303.
19. Wubbolts R, Leckie RS, Veenhuizen PT et al. Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J Biol Chem 2003; 278: 10963-72.
20. Fevrier B, Raposo G. Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol 2004; 16: 415-21.
21. Kharaziha P, Ceder S, Li Q, Panaretakis T. Tumor cell-derived exosomes: a message in a bottle. Biochim Biophys Acta 2012; 1826: 103-11.
22. Trajkovic K, Hsu C, Chiantia S et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 2008; 319: 1244-7.
23. Meckes DG Jr, Raab-Traub N. Microvesicles and viral infection. J Virol 2011; 85: 12844-54.
24. Chairoungdua A, Smith DL, Pochard P, Hull M, Caplan MJ. Exosome release of beta-catenin: a novel mechanism that antagonizes Wnt signaling. J Cell Biol 2010; 190: 1079-91.
25. Gan X, Gould SJ. Identification of an inhibitory budding signal that blocks the release of HIV particles and exosome/microvesicle proteins. Mol Biol Cell 2011; 22: 817-30.
26. Hsu C, Morohashi Y, Yoshimura S et al. Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. J Cell Biol 2010; 189: 223-32.
27. Ostrowski M, Carmo NB, Krumeich S et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 2010; 12: 19-30.
28. Singh RK, Mizuno K, Wasmeier C et al. Distinct and opposing roles for Rab27a/Mlph/MyoVa and Rab27b/Munc13-4 in mast cell secretion. FEBS J 2013; 280: 892-903.
29. Fukuda M. Rab27 effectors, pleiotropic regulators in secretory pathways. Traffic 2013; 14: 949-63.
30. Zitvogel L, Regnault A, Lozier A et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med 1998; 4: 594-600.
31. Savina A, Fader CM, Damiani MT, Colombo MI. Rab11 promotes docking and fusion of multivesicular bodies in a calcium-dependent manner. Traffic 2005; 6: 131-43.
32. Clayton A, Tabi Z. Exosomes and the MICA-NKG2D system in cancer. Blood Cells Mol Dis 2005; 34: 206-13.
33. Blott EJ, Griffiths GM. Secretory lysosomes. Nat Rev Mol Cell Biol 2002; 3: 122-31.
34. Wickman G, Julian L, Olson MF. How apoptotic cells aid in the removal of their own cold dead bodies. Cell Death Differ 2012; 19: 735-42.
35. Muralidharan-Chari V, Clancy JW, Sedgwick A, D'Souza-Schorey C. Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 2010; 123: 1603-11.
36. Conde-Vancells J, Rodriguez-Suarez E, Gonzalez E et al. Candidate biomarkers in exosome-like vesicles purified from rat and mouse urine samples. Proteomics Clin Appl 2010; 4: 416-25.
37. Carayon K, Chaoui K, Ronzier E et al. Proteolipidic composition of exosomes changes during reticulocyte maturation. J Biol Chem 2011; 286: 34426-39.
38. Subra C, Laulagnier K, Perret B, Record M. Exosome lipidomics unravels lipid sorting at the level of multivesicular bodies. Biochimie 2007; 89: 205-12.
39. Blanc L, De Gassart A, Geminard C, Bette-Bobillo P, Vidal M. Exosome release by reticulocytes-an integral part of the red blood cell differentiation system. Blood Cells Mol Dis 2005; 35: 21-6.
40. Rabesandratana H, Toutant JP, Reggio H, Vidal M. Decay-accelerating factor (CD55) and membrane inhibitor of reactive lysis (CD59) are released within exosomes during In vitro maturation of reticulocytes. Blood 1998; 91: 2573-80.
41. Clayton A, Turkes A, Dewitt S, Steadman R, Mason MD, Hallett MB. Adhesion and signaling by B cell-derived exosomes: the role of integrins. Faseb J 2004; 18: 977-9.
42. Thery C, Duban L, Segura E, Veron P, Lantz O, Amigorena S. Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes. Nat Immunol 2002; 3: 1156-62.
43. Little KM, Smalley DM, Harthun NL, Ley K. The plasma microparticle proteome. Semin Thromb Hemost 2010; 36: 845-56.
44. Segura E, Guerin C, Hogg N, Amigorena S, Thery C. CD8+ dendritic cells use LFA-1 to capture MHC-peptide complexes from exosomes in vivo. J Immunol 2007; 179: 1489-96.
45. Muntasell A, Berger AC, Roche PA. T cell-induced secretion of MHC class II-peptide complexes on B cell exosomes. EMBO J 2007; 26: 4263-72.
46. Azevedo LC, Janiszewski M, Pontieri V et al. Platelet-derived exosomes from septic shock patients induce myocardial dysfunction. Crit Care 2007; 11: R120.
47. Andre F, Schartz NE, Chaput N et al. Tumor-derived exosomes: a new source of tumor rejection antigens. Vaccine 2002; 20(Suppl 4): A28-31.
48. Hulsmans M, Holvoet P. MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. Cardiovasc Res 2013; 100: 7-18.
49. Bakhti M, Winter C, Simons M. Inhibition of myelin membrane sheath formation by oligodendrocyte-derived exosome-like vesicles. J Biol Chem 2011; 286: 787-96.
50. Ng YH, Rome S, Jalabert A et al. Endometrial exosomes/microvesicles in the uterine microenvironment: a new paradigm for embryo-endometrial cross talk at implantation. PLoS ONE 2013; 8: e58502.
51. Kahlert C, Kalluri R. Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med (Berl) 2013; 91: 431-7.
52. Bobrie A, Krumeich S, Reyal F et al. Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer Res 2012; 72: 4920-30.
53. Principe S, Jones EE, Kim Y et al. In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. Proteomics 2013; 13: 1667-71.
54. Simona F, Laura S, Simona T, Riccardo A. Contribution of proteomics to understanding the role of tumor-derived exosomes in cancer progression: state of the art and new perspectives. Proteomics 2013; 13: 1581-94.
55. Choi DS, Park JO, Jang SC et al. Proteomic analysis of microvesicles derived from human colorectal cancer ascites. Proteomics 2011; 11: 2745-51.
56. Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics 2010; 73: 1907-20.
57. Chiba M, Kimura M, Asari S. Exosomes secreted from human colorectal cancer cell lines contain mRNAs, microRNAs and natural antisense RNAs, that can transfer into the human hepatoma HepG2 and lung cancer A549 cell lines. Oncol Rep 2012; 28: 1551-8.
58. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9: 654-9.
59. Bobrie A, Colombo M, Raposo G, Thery C. Exosome secretion: molecular mechanisms and roles in immune responses. Traffic 2011; 12: 1659-68.
60. Ratajczak J, Miekus K, Kucia M et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 2006; 20: 847-56.
61. Leibovici J, Itzhaki O, Huszar M, Sinai J. The tumor microenvironment: part 1. Immunotherapy 2011; 3: 1367-84.
62. Kato Y, Ozawa S, Miyamoto C et al. Acidic extracellular microenvironment and cancer. Cancer Cell Int 2013; 13: 89.
63. Peinado H, Aleckovic M, Lavotshkin S et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 2012; 18: 883-91.
64. Zhou W, Fong MY, Min Y et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell 2014; 25: 501-15.
65. Ono M, Kosaka N, Tominaga N et al. Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells. Sci Signal 2014; 7: ra63.
66. Khan S, Aspe JR, Asumen MG et al. Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential. Br J Cancer 2009; 100: 1073-86.
67. Higginbotham JN, Demory Beckler M, Gephart JD et al. Amphiregulin exosomes increase cancer cell invasion. Curr Biol 2011; 21: 779-86.
68. Deng Z, Cheng Z, Xiang X et al. Tumor cell cross talk with tumor-associated leukocytes leads to induction of tumor exosomal fibronectin and promotes tumor progression. Am J Pathol 2012; 180: 390-8.
69. Sheldon H, Heikamp E, Turley H et al. New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes. Blood 2010; 116: 2385-94.
70. Dolo V, Ginestra A, Cassara D, Ghersi G, Nagase H, Vittorelli ML. Shed membrane vesicles and selective localization of gelatinases and MMP-9/TIMP-1 complexes. Ann N Y Acad Sci 1999; 878: 497-9.
71. Graves LE, Ariztia EV, Navari JR, Matzel HJ, Stack MS, Fishman DA. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res 2004; 64: 7045-9.
72. Whiteside TL. Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes). Biochem Soc Trans 2013; 41: 245-51.
73. Epple LM, Griffiths SG, Dechkovskaia AM et al. Medulloblastoma exosome proteomics yield functional roles for extracellular vesicles. PLoS ONE 2012; 7: e42064.
74. Liu C, Yu S, Kappes JR et al. Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. Blood 2007; 109: 4336-42.
75. Corcoran C, Friel AM, Duffy MJ, Crown J, O'Driscoll L. Intracellular and extracellular microRNAs in breast cancer. Clin Chem 2011; 57: 18-32.
76. Lotvall J, Valadi H. Cell to cell signalling via exosomes through esRNA. Cell Adh Migr 2007; 1: 156-8.
77. Koles K, Budnik V. Exosomes go with the Wnt. Cell Logist 2012; 2: 169-73.
78. Ekstrom K, Omar O, Graneli C, Wang X, Vazirisani F, Thomsen P. Monocyte exosomes stimulate the osteogenic gene expression of mesenchymal stem cells. PLoS ONE 2013; 8: e75227.
79. Zhou H, Cheruvanky A, Hu X et al. Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int 2008; 74: 613-21.
80. Simpson RJ, Kalra H, Mathivanan S. ExoCarta as a resource for exosomal research. J Extracell Vesicles 2012; 1: 18374 - http://dx.doi.org/10.3402/jev.v1i0.18374.
81. Graner MW, Alzate O, Dechkovskaia AM et al. Proteomic and immunologic analyses of brain tumor exosomes. FASEB J 2009; 23: 1541-57.
82. Stasevich TJ, McNally JG. Assembly of the transcription machinery: ordered and stable, random and dynamic, or both? Chromosoma 2011; 120: 533-45.
83. Ahmed KA, Xiang J. Mechanisms of cellular communication through intercellular protein transfer. J Cell Mod Med 2011; 15: 1458-73.